Oncology & Cancer

The benefits of anti-CD69 antibodies for future cancer therapies

CD8+ T cells, a vital component of the immune system that provides immunity against cancer, have been the focal point of anti-cancer therapies. Recent studies have identified two major subpopulations of these cells present ...

page 7 from 40